Pediatric bronchial Dieulafoy's disease: a biopsy-sparing bronchoscopic approach with selective bronchial artery embolization - Takeaways - MDSpire

Pediatric bronchial Dieulafoy's disease: a biopsy-sparing bronchoscopic approach with selective bronchial artery embolization

  • By

  • Weiqing Liu

  • Jiasi Zhou

  • Jia Guo

  • Tuanjie Wang

  • Yuping Xu

  • Shujun Li

  • May 8, 2026

  • 0 min

Share

  • 1

    Bronchial Dieulafoy's disease (BDD) is a rare vascular malformation in children, leading to severe hemorrhage due to aberrant submucosal arteries.

  • 2

    A standardized pathway emphasizing biopsy-sparing bronchoscopy and early bronchial artery embolization (BAE) was evaluated for pediatric BDD management.

  • 3

    In a study of three patients, all achieved immediate hemostasis after superselective embolization, with no major complications reported.

  • 4

    Computed tomography angiography (CTA) failed to identify vascular lesions in all cases, highlighting its limited diagnostic yield in pediatric BDD.

  • 5

    The study suggests that a biopsy-sparing approach with early BAE is feasible and safe, achieving favorable short-term outcomes in pediatric BDD.

Original Source(s)

Pediatric bronchial Dieulafoy's disease: a biopsy-sparing bronchoscopic approach with selective bronchial artery embolization

  • by Weiqing Liu, Jiasi Zhou, Jia Guo, Tuanjie Wang, Yuping Xu, Shujun Li

  • May 8, 2026

Related Content

Makary Resigns as FDA Commissioner Following Policy Disputes

Transition follows disputes over vaccine policy, food additive regulation, and flavored vaping product authorization

Clinical characteristics and risk factors of necrotizing pneumonia secondary to severe pneumonia in children

Antibiotics May Not Help Mild COVID

A retrospective cohort study of more than 520,000 hospitalized patients found no clinically meaningful improvement in deterioration or mortality with early treatment targeting community-acquired pneumonia.